---
figid: PMC9491642__46fig1
figtitle: Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for
  the treatment of asthma
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC9491642
filename: 46fig1.jpg
figlink: /pmc/articles/PMC9491642/figure/F1/
number: F1
caption: Schematic diagram of the interleukin (IL)-4/IL-13/signal transducer and activator
  of transcription factor (STAT)-6 signalling pathways []. Both IL-4 and IL-13 signal
  via the IL-4Rα, a component of the type I (IL-4Rα and γc) and type II receptors
  (IL-4Rα and IL-13Rα1). IL-4 signals via both type I and II receptor pathways, whereas
  IL-13 signals only via the type II IL-4R. IL-13 also binds to the IL-13Rα2 chain,
  which does not contain a transmembrane-signalling domain and is thought to act as
  a decoy receptor. γc activates janus kinase (JAK)3, whereas IL-13Rα1 activates tyrosine
  kinase 2 (TYK2) and JAK2. Activated JAKs then phosphorylate STAT-6. Phosphorylated
  STAT-6 dimerises, migrates to the nucleus, and binds to the promoters of the IL-4
  and IL-13 responsive genes, such as those associated with T-helper type 2 (Th2)
  cell differentiation, airway inflammation, airway hyperresponsiveness (AHR) and
  mucus production.
papertitle: Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for
  the treatment of asthma.
reftext: C. K. Oh, et al. Eur Respir Rev. 2010 Mar;19(115):46-54.
year: '2010'
doi: 10.1183/09059180.00007609
journal_title: European Respiratory Review
journal_nlm_ta: Eur Respir Rev
publisher_name: European Respiratory Society
keywords: Asthma | interleukin-4 | interleukin-13 | monoclonal antibody | signal transducer
  and activator of transcription factor-6
automl_pathway: 0.9560137
figid_alias: PMC9491642__F1
figtype: Figure
redirect_from: /figures/PMC9491642__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9491642__46fig1.html
  '@type': Dataset
  description: Schematic diagram of the interleukin (IL)-4/IL-13/signal transducer
    and activator of transcription factor (STAT)-6 signalling pathways []. Both IL-4
    and IL-13 signal via the IL-4Rα, a component of the type I (IL-4Rα and γc) and
    type II receptors (IL-4Rα and IL-13Rα1). IL-4 signals via both type I and II receptor
    pathways, whereas IL-13 signals only via the type II IL-4R. IL-13 also binds to
    the IL-13Rα2 chain, which does not contain a transmembrane-signalling domain and
    is thought to act as a decoy receptor. γc activates janus kinase (JAK)3, whereas
    IL-13Rα1 activates tyrosine kinase 2 (TYK2) and JAK2. Activated JAKs then phosphorylate
    STAT-6. Phosphorylated STAT-6 dimerises, migrates to the nucleus, and binds to
    the promoters of the IL-4 and IL-13 responsive genes, such as those associated
    with T-helper type 2 (Th2) cell differentiation, airway inflammation, airway hyperresponsiveness
    (AHR) and mucus production.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL4
  - IL4R
  - STAT6
  - JAK3
  - IL13RA2
  - IL13
  - IL13RA1
  - TYK2
  - JAK2
  - AHR
  - il13
  - il4
  - il4r.1
  - stat6
  - jak3
  - il13ra2
  - il13ra1
  - tyk2
  - jak2b
  - th2
  - inflammation
---
